These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 549530)
1. Pharmacological studies on new oncostatic acridine derivatives. I. Acute and subchronic action. Błaszczyk B; Giełdanowski J; Patkowski J; Kowalczyk-Bronisz SH Arch Immunol Ther Exp (Warsz); 1979; 27(6):749-63. PubMed ID: 549530 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies on 1-nitro-9-alkyl acridine derivatives. I. Acute and subchronic action. Kowalczyk-Bronisz SH; Blaszczyk B; Gieldanowski J; Patkowski J; Pelczarska A Arch Immunol Ther Exp (Warsz); 1975; 23(3):391-413. PubMed ID: 1217965 [TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacologic investigations on a new group of acridine derivatives with oncostatic activity. I. Acute and subchronic action. Giełdanowski J; Wieczorek Z; Kowalczyk-Bronisz SH; Kowalewska D; Błaszczyk B; Skibiński G; Zimecki M Arch Immunol Ther Exp (Warsz); 1980; 28(5):735-54. PubMed ID: 7212981 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological studies on new oncostatic acridine derivatives. II. Chronic action. Błaszczyk B; Giełdanowski J; Patkowski J; Kowalczyk-Bronisz SH Arch Immunol Ther Exp (Warsz); 1979; 27(6):765-76. PubMed ID: 549531 [TBL] [Abstract][Full Text] [Related]
5. Preclinical pharmacologic investigations on 1-nitro-9-(dimethylaminopropylamino)-acridine and its N-oxide. I. Acute and subchronic activity. Gieldanowski J; Patkowski J; Szaga B; Teodorczyk J Arch Immunol Ther Exp (Warsz); 1972; 20(3):399-417. PubMed ID: 5055687 [No Abstract] [Full Text] [Related]
6. Comparison of antitumor properties of nitracrine and amsacrine analogs. Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605 [TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacologic studies on 1-nitro-9-(dimethylamino)-acridine and 1-nitro-10-(dimethylaminoethyl)-9-acridone. I. Acute and subacute action. Pelczarska A; Kowalczyk-Bronisz SH; Blaszczyk B; Gieldanowski J; Patkowski J Arch Immunol Ther Exp (Warsz); 1974; 22(6):823-42. PubMed ID: 4451445 [No Abstract] [Full Text] [Related]
8. Studies of pharmacological activity several acridine derivatives with cytostatic and oncostatic properties. Gieldanowski J Mater Med Pol; 1976; 8(3):252-7. PubMed ID: 1034858 [No Abstract] [Full Text] [Related]
10. Preclinical pharmacologic investigations on a new group of acridine derivatives with oncostatic activity. II. Chronic action. Giełdanowski J; Wieczorek Z; Kowalczyk-Bronisz SH; Kowalewska D; Błaszczyk B; Skibiński G; Zimecki M Arch Immunol Ther Exp (Warsz); 1980; 28(5):755-76. PubMed ID: 7212982 [TBL] [Abstract][Full Text] [Related]
11. Mutagenic activity of some 9-aminoalkyl acridine derivatives on S. typhimurium. Kalinowska E; Chorazy M Mutat Res; 1980 May; 78(1):7-15. PubMed ID: 6991931 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide. Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors. Mazerska Z; Lukowicz J; Konopa J Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249 [TBL] [Abstract][Full Text] [Related]
15. Preclinical pharmacologic studies on 1-nitro-9-(dimethylaminopropylamino)-acridine and its n-oxide. II. Chronic action. Gieldanowski J; Patkowski J; Szaga B; Teodorczyk J Arch Immunol Ther Exp (Warsz); 1972; 20(3):419-44. PubMed ID: 5055688 [No Abstract] [Full Text] [Related]
16. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties. Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834 [TBL] [Abstract][Full Text] [Related]
17. Studies on vomitory effect of some acridine compounds. Kowalczyk-Bronisz SH Arch Immunol Ther Exp (Warsz); 1980; 28(5):777-82. PubMed ID: 7212983 [TBL] [Abstract][Full Text] [Related]
18. Ledakrin--anticancerous medicine 1-nitro-9(3-dimethylaminopropylamino)-acridine -2HCl-H2O. Ledochowski A Mater Med Pol; 1976; 8(3):237-51. PubMed ID: 796591 [No Abstract] [Full Text] [Related]
19. General pharmacology of recombinant human basic fibroblast growth factor. Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346 [TBL] [Abstract][Full Text] [Related]